What compounding standard does Arkansas follow for good practices?

Arkansas follows the compounding standards established by the United States Pharmacopeia, specifically USP 797. This standard outlines the practices aimed at ensuring the quality and safety of compounded sterile preparations (CSPs). The regulations set forth in USP 797 are intended to minimize the risks associated with the preparation of CSPs, focusing on aspects such as the environment in which compounding occurs, the training and competencies of personnel, and the procedures for compounding itself.

The importance of USP 797 is emphasized in its detailed guidelines for maintaining cleanliness and sterility, as well as establishing quality assurance practices that are essential in healthcare settings. Compliance with these standards is critical for pharmacies and other healthcare providers involved in the compounding of sterile products to enhance patient safety and ensure regulatory compliance.

Other options refer to different standards or guidelines that address various aspects of pharmaceutical practices. For instance, USP 600 relates to the quality standards for biologics, USP 800 provides guidelines for handling hazardous drugs, and CDC Guidelines focus on broader infection control measures rather than specifically on compounding. Hence, USP 797 is the correct choice when addressing compounding practices in Arkansas.